Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences

Brett D. Shepard, Davide De Forni, David R. McNamara et al. · 2008

Read Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences by Brett D. Shepard, Davide De Forni, David R. McNamara et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003096.txt.

Description

Brett Shepard, Davide De Forni, David McNamara and co-authors tested the protein TRAIL against HIV burden in 2008. During uncontrolled HIV disease, TRAIL and its receptor are increased. Sensitivity rises because the viral protein gp120 pushes the receptor up, while successful antiretroviral therapy brings TRAIL back down.

The title reports a beneficial effect of TRAIL on HIV burden without detectable immune consequences. Published in PLOS ONE, a treatment that cuts burden without immune harm would be notable. The study explores borrowing the body's own death signal against infected cells. Anyone can read the full text free of charge through the journal's open access site.

Catalog record

CREATORBrett D. Shepard, Davide De Forni, David R. McNamara et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003096

Browse the full library · About the Tower of Babel